AbbVie Highlights Innovative Research for People with Rheumatic Diseases with New Data at ACR Convergence 2020 Biotech Investing
Allergan, an AbbVie Company, Announces Positive Phase 3 Topline Results for Investigational AGN-190584 for the Treatment of Presbyopia Biotech Investing
MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing Psychedelics Investing
Aurinia Announces European Investigator-Initiated Trial to Evaluate Antiviral Activity of Voclosporin in Kidney Transplant Recipients with COVID-19 Biotech Investing
Aptose to Release Third Quarter Ended September 30, 2020 Financial Results and Hold Conference Call on November 10, 2020 Biotech Investing
Amgen Announces Participation Of Systemic Lupus Erythematosus Adaptive Clinical Trial In The FDA Complex Innovative Trial Designs Pilot Program Biotech Investing
Bausch + Lomb Introduces SimplifEYE IOL Delivery System For enVista® Toric And Monofocal Preloaded Intraocular Lenses Medical Device Investing
